ArticleFrontiers in cardiovascular medicine2025
Radiotherapy for recurrent venous malformation involving the thigh and pelvic organs while preserving organ function: a case report.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Venous malformations (VMs) are congenital vascular anomalies that cause significant pain and dysfunction. Although surgery is the primary treatment, no standardized guidelines exist for extensive or recurrent cases in which surgery is not feasible. Additionally, the role of radiotherapy (RT) in the management of VMs remains unclear. Methods: A 24-year-old woman with extensive, recurrent VM involving the pelvic cavity, right thigh, and buttocks underwent multiple surgeries and sclerotherapy for over 10 years; however, the disease progressed, infiltrating the pelvic organs, and posed a risk to fertility. The patient presented with severe pain, ureteral obstruction, and menstrual irregularities, all of which significantly affected her quality of life. Considering the high morbidity associated with further surgery, definitive RT was performed. The patient received intensity-modulated radiotherapy (IMRT) at a total dose of 43 Gy in 20 fractions, preceded by ovarian transposition to preserve fertility. Results: After the treatment, the patient experienced remarkable symptom relief, including pain resolution and improvement in menstrual regularity. Follow-up imaging over five years demonstrated a continued reduction in the lesion size. The menstrual cycles remained regular, and anti-Müllerian hormone levels remained within the normal range. Conclusion: This case demonstrates the potential of RT as an effective treatment for extensive, recurrent pelvic VMs. RT achieves durable disease control while preserving ovarian function, highlighting its role as a viable alternative in select cases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.